記憶度
12問
32問
0問
0問
0問
アカウント登録して、解答結果を保存しよう
問題一覧
1
What are the 2 branches of pharmacotherapeutics.
Pharmacokinetics and Pharmacodynamics.
2
What are the parts of pharmacokinetics.
Absorption, Distribution and Elimination.
3
What are the branch of pharmacodynamics
Systemic effect and Cellular effect
4
In what century did materia medica develop?
1st century.
5
It is science of drug preparation and medical use of drugs began to develop as the precursor of pharmacology
De materia medica.
6
He is the author of de materia medica.
Pedanius dioscorides.
7
used to prepare all sort of strange concoctions, including those of herbs, in order to treat their patients.
Apothecaries
8
What century did Some apothecaries decided they had no interest in treating patients. and they were more interested in preparing medical compounds instead
18th century
9
Who is the father of pharmacology.
Oswald Schmiedeberg
10
He came along that pharmacology became a true and distinct scientific branch of its own in a big way.
Oswald Schmiedeberg
11
He studied the pharmacology of various compounds, including chloroform, and published an important text called the Outline of Pharmacology
Oswald Schmiedeberg
12
Advances in chemistry and the further development of physiology laid the foundation needed for understanding how drugs work at the organ and tissue levels.
Advancement in Pharmacology
13
The relation of the individual’s genetic makeup to his or her response to specific drugs—is close to becoming a practical area of therapy
Pharmacogenomics
14
In what century did pharmacogenomic discover.
20th century
15
This field of study suggest that our genetic make up can affect our response to a certain drug(T/F)
True.
16
common use include • inorganic ions • nonpeptide organic molecules • small peptides and proteins • nucleic acids • lipids and • carbohydrates.
Drugs.
17
Drugs used for?
Diagnosis, Mitigation, Prevention and Cure of diseases.
18
It is a chemical compound of synthetic, semisynthetic, natural or biological origin which interacts with human or animal cells
Drugs.
19
Almost all the several thousand drugs currently available can be arranged into about 70 groups
True.
20
Many of the drugs within each group are very different in pharmacodynamic actions and in their pharmacokinetic properties as well.
False.
21
For most groups, one or more prototype drugs can be identified that typify the most important characteristics of the group.
True.
22
Sizes from MW 7 (Lithium) to over MW 50,000 (thrombolytic enzymes, other proteins)
Size and molecular weight
23
Majority of drugs have MW between 100 and 1000.
True.
24
which usually result in irreversible action.
Covalent bond
25
Somewhat weaker (between a cation and an anion)
Electrostatic bonds.
26
Much weaker interactions (hydrogen bond, van der Waals interactions, and hydrophobic bonds)
True.
27
The shape of a drug molecule must be such as to permit binding to its receptor site via the bonds
Drug shape.
28
The drug’s shape is complementary to that of the receptor site in the same way that a key is complementary to a lock.
Drug shape.
29
Compounds that have the same chemical formula but different in structure or spatial arrangement.
Chirality.
30
Alter or modulate the normal physiologic functions Interaction of drug molecules and cellular components (receptor) alter the functions of the latter.
Functional modifier
31
Supplement endogenous substances that are lacking or deficient in the body
Replenishers
32
used to determine the presence or absence of a condition/disease
Diagnostic agent.
33
Used to kill or inhibit growth of cells considered as foreign to the body
Chemotherapeutics.
34
Who discover and follows the principle of “selective toxicity” (The property of certain chemicals to kill one type of organism while not harming another.)
Paul ehrlich
35
The study of how drugs move into, through and out of the body including delivery to their target sites; deals with ADME
Pharmacokinetics
36
the drug’s uptake from the site of administration to the systemic circulation
Absorption
37
the drug’s movement to various sites after entering systemic circulation
Distribution
38
the drug’s conversion to metabolite
Metabolism
39
the drug’s removal from the body
Excretion
40
The release of active ingredient from its dosage form
Liberation
41
rate-limiting step in absorption of solid dosage forms and consequently onset, intensity, and duration of action of the drug.
Liberation
42
What are the expections in liberation.
Oral, Parenteral and Transdermal.
43
dissolve much readily when compared to the drugs in its free form
Salt form.
44
Factors that influence the dissolution rate:
Crystal form or amorphous drug forms.
45
Choramphenicol palmitate is inactive in crystalline form but when it is administered in amorphous form, absorption in the GIT is rapid and with good therapeutic response.
True.
46
100% amorphous
Semilente
47
30% amorphous and 70% crystalline
Lente
48
(100% crystalline)
Ultralente
49
The proportion of a drug that is delivered to its site of action in the body.
Bioavailability
50
High dose = high drug absorption
True.
51
High blood supply = greater extent/ faster absorption
True.
52
The large surface area of the gastro-intestinal tract is due to the presence of macrovilli and microvilli in small intestines (Duodenum)
True.
53
Skin (Caucasian Adult)
1.73 sq. m
54
Lungs
70 sq. m
55
Gastro-intestinal tract
120-200 sq. m
56
Essential organ for weakly basic drugs
Intestine
57
Essential for absorption of weakly acidic drugs
Stomach
58
Highly acidic (pH 1.5-2) (pH 2-6; Fasting ph.
Stomach
59
Covered with thick mucus layer
Stomach
60
Has villi, large surface area
Intestine
61
Short surface area
Stomach
62
Not good as an absorption site
Stomach
63
Good for absorption
Intestine
64
has the greatest capacity for the absorption of drugs from the GI tract
Duodenum
65
some drugs are partially metabolized in the liver or portal vein before passing into circulatory system
First pass effect
66
some drugs travel intact through the biliary tract after initial absorption and are then reabsorbed into bloodstream through the intestine.
Enterohepatic recycling
67
A drug’s route of administration affects its rate and extent of absorption. (T/F)
True.
68
moving material in and out of the cell
Transport mechanism
69
movement of molecules based on the differences in the concentration across 2 region
Diffusion
70
molecules are transported by the movement of a liquid or a gaseous vehicle
Convection
71
Process of drug movement across the cell
Transcellular
72
Process of drug movement that goes through gaps or tight junction between cell
Paracellular
73
higher concentration to lower concentration movement of small lipophilic molecule along a conc. Gradient
Passive transport
74
This law states that the rate of diffusion of a solute molecule through a barrier is proportional to the concentration gradient.
Ficks first law
75
This law states that the change in concentration with respect to time at a particular region is proportional to the change in the concentration gradient at that point in the system.
Ficks second law
76
A passive process requiring no cellular energy
Facilitated transport
77
Drug moves along a concentration gradient and Saturable and structurally selective
Facilitated transport
78
From lower concentration to higher concentration “pushing a rock uphill” which requires cellular energy
Active transport
79
small drug molecules simply move along with fluid through the pores in cell walls
Pore transport
80
MEDIATED through “water-filled pores/channels/aquaporins
Pore transport
81
Cell eating.
Phagocytosis
82
Cell drinking.
Pinocytosis
83
it is a process by which cells absorb molecules (such as proteins) by engulfing them
Endocytosis
84
Complex of organic anion with cation
Ion pair transport
85
Linkage of ionized drug with oppositely charge ion (neutral complex)
Ion pair transport
86
What are the parts of pharmacokinetics.
Absorption, Distribution and Elimination